SRS 2025: Intercontinental robotic cardiac surgery completed using SSi Mantra 3 system

Sudhir Srivastava performing a robotic atrial septal defect closure remotely from the global headquarters of the Institute of Research Against Digestive Cancer in Strasbourg, France

SS Innovations International has announced the successful completion of an intercontinental robotic cardiac telesurgery utilising the company’s SSi Mantra 3 surgical robotic system.

Sudhir Srivastava, who is the company’s chairman and chief executive officer, performed the cardiac procedure, a robotic atrial septal defect closure, remotely from the global headquarters of the Institute of Research Against Digestive Cancer (IRCAD) in Strasbourg, France, during the Society of Robotic Surgery (SRS) annual meeting (16–20 July, Strasbourg, France) at a transmission distance of more than 4,000 miles to the operating room at the Sri Aurobindo Institute of Medical Sciences (SAIMS) in Indore, India.

Patient-side support in Indore was coordinated by Lalit Malik (Manipal Hospital, Jaipur, India), Ram Krishna Shukla (SAIMS, Indore, India), Bipin Arya (SAIMS, Indore, India), and the SS Innovations and SAIMS teams.

The live telesurgery was moderated by robotic cardiac surgeon Husam H Balkhy (University of Chicago Medicine, Chicago, USA), president of the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS).

“I would like to extend my gratitude to Dr. Vipul Patel, chairman of the Society of Robotic Surgery for this opportunity at the SRS 2025 conference, Dr Mohit Bhandari, the IRCAD India team, and the entire SS Innovations team whose dedication and innovation made the world’s first intercontinental robotic cardiac telesurgery possible,” commented Srivastava. “This historic achievement not only demonstrates the advanced capabilities of our SSi Mantra 3 surgical robotic system but also further paves the way for redefining and democratising global delivery of complex cardiac care, especially in regions with limited access to surgical expertise.”

The Company’s SSi Mantra surgical robotic technology platform, including its telesurgery capabilities, addresses traditional obstacles related to travel, time, cost, and surgical accessibility, creating a more efficient and equitable medical standard for both patients and surgeons, the company says in a press release.

To date, 35 telesurgeries including 10 cardiac procedures, and a total of 250 cardiac procedures have been completed utilising the SSi Mantra surgical robotic system.


LEAVE A REPLY

Please enter your comment!
Please enter your name here